Articles published by NovaBay Pharmaceuticals, Inc.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230426006103/en/841167/5/nby_logo.jpg)
Via Business Wire
Tickers
NBY
![](https://mms.businesswire.com/media/20230421005008/en/1768777/22/C%2BJ_cream_8oz_Pic.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://mms.businesswire.com/media/20230314005317/en/1737837/22/Eyeganics_FB_Ad_2.jpg)
![](https://mms.businesswire.com/media/20230307005090/en/1730035/22/BryPhoto_Avenova_2023_0209_16.jpg)
![](https://mms.businesswire.com/media/20230206005067/en/841167/5/nby_logo.jpg)
![](https://mms.businesswire.com/media/20230131005342/en/841167/5/nby_logo.jpg)
NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023
January 31, 2023
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NovaBay Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 14, 2022
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split
November 14, 2022
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://mms.businesswire.com/media/20221026005007/en/1609747/4/PP_Niacinamide_2303_4x5_%28002%29.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NovaBay Pharmaceuticals to Present at the LD Micro Main Event XV
October 19, 2022
Via Business Wire
Tickers
NBY
![](https://mms.businesswire.com/media/20221018005510/en/841167/5/nby_logo.jpg)
![](https://mms.businesswire.com/media/20221010005181/en/841167/5/nby_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference
September 23, 2022
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
September 22, 2022
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
NBY
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.